Evidence map›Paper›PMID 38185776›Full record

ArticleDrug delivery and translational research2024

3D-printed Laponite/Alginate hydrogel-based suppositories for versatile drug loading and release.

Elena Munoz-Perez, J Rubio-Retama, Lorena Cussó, Manoli Igartua, Rosa Maria Hernandez, Edorta Santos-Vizcaino

Open access · hybridAbstract read
In one paragraph

Article in Drug delivery and translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Elena Munoz-PerezNanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006, Vitoria Gasteiz, Spain.
J Rubio-RetamaDepartment of Chemistry in Pharmaceutical Science, Complutense University of Madrid, 28040, Madrid, Spain.
Lorena CussóUnidad de Imagen Avanzada, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
Manoli IgartuaNanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006, Vitoria Gasteiz, Spain.
Rosa Maria HernandezNanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006, Vitoria Gasteiz, Spain. rosa.hernandez@ehu.eus.
Edorta Santos-VizcainoNanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006, Vitoria Gasteiz, Spain. edorta.santos@ehu.eus.ORCID 0000-0001-7064-4563
University of the Basque Country · ESInstituto de Salud Carlos III · ESUniversidad Complutense de Madrid · ESUniversitat de Miguel Hernández d'Elx · ES

Funding

DESIGNER DRUG INDUCED NEUROPATHOLOGYN01DA007403 · NIDA · NEW YORK UNIVERSITY · PI AZMITIG, EFRAIN · 1990 to 1992
–
Comunidad de Madrid S2022/BMD-7403 RENIM-CMEusko Jaurlaritza IT1448-22Eusko Jaurlaritza PRE_2022_2_0115Fundación Vital Fundazioa vital21/28Instituto de Salud Carlos III PT20/00044Ministerio de Ciencia e Innovación PID2021-122577OB-I00Ministerio de Ciencia e Innovación PID2021-123318-OB-I00
6 · The paper itself

Abstract

Traditional approaches to solid rectal therapies have halted progress, leading to a continual decline in the use of conventional suppositories. Additive manufacturing techniques have been recently explored as a suitable innovative tool for suppository fabrication. However, little advancement has been made in composition materials for 3D-printed suppository (3DPS) manufacturing and still, conventional vehicles are often used for construct fabrication, hindering the growth in the field. As a novelty, this study unveils a ground-breaking Laponite-alginate hydrogel-based 3DPS. Interestingly, this study proposes a novel approach for loading drugs into the 3DPS employing for the first time the post-printing loading. Thus, a passive loading strategy of molecular models is developed, demonstrating the versatility and capacity to load molecules of different charges and molecular sizes within the matrix systems. This novel strategy allows adapting the load of a wide range of drugs into a single ink, which simplifies and speeds up the 3DPS technological development process for drugs with different physico-chemical properties. Additionally, in this research, a displacement strategy of the three-dimensional Laponite matrices is developed in order to enhance the drug release capacity through the 3DPS and their disintegration capacity, resulting in a significant improvement of the drug diffusion through the hydrogel matrix and a rapid disintegration of the 3DPS. Finally, our study demonstrates that the obtained 3DPS have a suitable in vivo behavior, being non-obstructive and allowing the normal motility of the rats intestine.

Indexed as

AlginatesDrug LiberationHydrogelsPrinting, Three-DimensionalSilicatesAnimalsRatsSuppositoriesAlginatesHydrogelslaponiteSilicatesSuppositories3D printingAlginateDrug-deliveryLaponiteSemi-solid extrusion

Identifiers

PMID38185776
PMCPMC11499362
OpenAlexW4390651719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.